Risk of inadequate protein and micronutrient intakes in patients with PKU with an increased phe-tolerance: Impact of a micronutrient-dense protein substitute
Authors:
Open Access
- 4 October 2025
- journal article
- Published by Elsevier in Molecular Genetics and Metabolism Reports
- Vol. 45, 101264
Abstract
No abstract availableKeywords
Funding Information
- Danone
This publication has 25 references indexed in Scilit:
- European guidelines on diagnosis and treatment of phenylketonuria: First revisionMolecular Genetics and Metabolism, 2025
- ESPEN micronutrient guidelineClinical Nutrition, 2022
- The Genetic Landscape and Epidemiology of PhenylketonuriaThe American Journal of Human Genetics, 2020
- Anthropomorphic measurements and nutritional biomarkers after 5 years of BH 4 treatment in phenylketonuria patientsMolecular Genetics and Metabolism, 2018
- PKU patients on a relaxed diet may be at risk for micronutrient deficienciesEuropean Journal of Clinical Nutrition, 2013
- Micronutrient status in phenylketonuriaMolecular Genetics and Metabolism, 2013
- Long-term treatment with tetrahydrobiopterin in phenylketonuria: Treatment strategies and prediction of long-term respondersMolecular Genetics and Metabolism, 2012
- BH4 therapy impacts the nutrition status and intake in children with phenylketonuria: 2‐year follow‐upJournal of Inherited Metabolic Disease, 2010
- Long-chain polyunsaturated fatty acid status in phenylketonuric patients treated with tetrahydrobiopterinClinical Biochemistry, 2010
- Clinical and nutritional evaluation of phenylketonuric patients on tetrahydrobiopterin monotherapyMolecular Genetics and Metabolism, 2005